Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibodyof c7E3 Fab (abciximab; ReoProTM)

ISSN： 0969-6970

Source： Angiogenesis, Vol.3, Iss.1, 1999-01, pp. : 53-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

c7E3 Fab inhibits human tumor angiogenesis in a SCID mouse human skin xenograft model

By Nakada Marian Cao Gaoyuan Sassoli Patricia DeLisser Horace

Angiogenesis, Vol. 9, Iss. 4, 2006-12 ,pp. : 171-176

Springer Publishing Company

Access to resources Recommend Favorite

EFFECTS OF PLATELETS AND WHITE BLOOD CELLS AND ANTIPLATELET AGENT C7E3 (Reopro TM ) ON A NEW TEST OF PAF PROCOAGULANT ACTIVITY OF WHOLE BLOOD.

By Despotis G.J. Ikonomalou S. Levine V. Joiner-Maier D. Santoro S.A. Joist J.H.

Thrombosis Research, Vol. 86, Iss. 3, 1997-05 ,pp. : 205-219

Elsevier

Access to resources Recommend Favorite

The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, M 2 )

By Schwarz M. Nordt T. Bode C. Peter K.

Thrombosis Research, Vol. 107, Iss. 3, 2002-08 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Intravenous Administration of the Glycoprotein IIb-IIIa Receptor Antagonist 7E3 Induces Reperfusion of an Acute Thrombotic Occlusion of the Canine Coronary Artery - Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and ''clinical restenosis''

By Shetler T.J. Bailey B.D. Jakubowski J.A. Jackson C.V.

Thrombosis Research, Vol. 90, Iss. 2, 1998-04 ,pp. : 95-100

Elsevier

Access to resources Recommend Favorite

Inhibition of Platelet-Mediated Clot Retraction by Integrin Antagonists - Comparative platelet binding affinity profiles with DMP728 and c7E3 (Abstract)

By Hantgan R.R. Mousa S.A.

Thrombosis Research, Vol. 89, Iss. 6, 1998-03 ,pp. : 271-279

Elsevier

Access to resources Recommend Favorite